BioCentury | Jul 14, 2008
Finance

Ebb & Flow

Following in the footsteps of PDL (NASDAQ:PDLI) and Enzon (NYSE:ENZ), Angiotech (TSX:ANP; NASDAQ:ANPI) last week said it will spin out everything except royalties derived from paclitaxel-eluting stents into a separate private company called Angiotech Pharmaceutical...
BioCentury | Oct 13, 2003
Company News

Ionian Technologies Inc. board of directors update

Ionian Technologies Inc. , Upland, Calif. Business: Supply/Service Appointed: J. Craig Venter, founder and chairman of The Institute for Genomic Research WIR Staff...
Items per page:
1 - 2 of 2
BioCentury | Jul 14, 2008
Finance

Ebb & Flow

Following in the footsteps of PDL (NASDAQ:PDLI) and Enzon (NYSE:ENZ), Angiotech (TSX:ANP; NASDAQ:ANPI) last week said it will spin out everything except royalties derived from paclitaxel-eluting stents into a separate private company called Angiotech Pharmaceutical...
BioCentury | Oct 13, 2003
Company News

Ionian Technologies Inc. board of directors update

Ionian Technologies Inc. , Upland, Calif. Business: Supply/Service Appointed: J. Craig Venter, founder and chairman of The Institute for Genomic Research WIR Staff...
Items per page:
1 - 2 of 2